TrialHuman vaccines & immunotherapeutics2020

Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial.

Joyce Ojeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.